AGIOS PHARMACEUTICALS, INC. Available-for-sale Securities, Gross Realized Gain (Loss)
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2017-05-04
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-03-31 was $0.00.
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2016-12-31 was $0.00.
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2016-09-30 was $0.00.
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2016-06-30 was $0.00.
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for fiscal 2016 was $0.00.
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for fiscal 2014 was $0.00.
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for fiscal 2013 was $0.00.
- AGIOS PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2017-05-04 | $0.00 derived: sum of 3 quarters · filed 2017-05-04 | $0.00 derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $0.00 derived: sum of 2 quarters · filed 2017-02-16 | $0.00 derived: sum of 3 quarters · filed 2017-02-16 | $0.00 10-K · filed 2017-02-16 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2016-05-09 | $0.00 derived: sum of 3 quarters · filed 2016-05-09 | $0.00 derived: sum of 4 quarters · filed 2016-05-09 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | $0.00 derived: sum of 3 quarters · filed 2016-02-26 | $0.00 10-K · filed 2016-02-26 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | $0.00 derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2015-08-07 | $0.00 derived: sum of 3 quarters · filed 2016-02-26 | $0.00 derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | $0.00 derived: sum of 3 quarters · filed 2016-02-26 | $0.00 derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | $0.00 derived: sum of 3 quarters · filed 2016-02-26 | $0.00 10-K · filed 2016-02-26 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-24 | |||
| 2011-12-31 | $1.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |